Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 2 |
2012 | 1 |
2013 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic mice.
J Alzheimers Dis. 2013;36(3):589-96. doi: 10.3233/JAD-130071.
J Alzheimers Dis. 2013.
PMID: 23645096
Chronic administration of dimebon ameliorates pathology in TauP301S transgenic mice.
Peters OM, Connor-Robson N, Sokolov VB, Aksinenko AY, Kukharsky MS, Bachurin SO, Ninkina N, Buchman VL.
Peters OM, et al.
J Alzheimers Dis. 2013;33(4):1041-9. doi: 10.3233/JAD-2012-121732.
J Alzheimers Dis. 2013.
PMID: 23099813
Item in Clipboard
Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice.
Bachurin SO, Shelkovnikova TA, Ustyugov AA, Peters O, Khritankova I, Afanasieva MA, Tarasova TV, Alentov II, Buchman VL, Ninkina NN.
Bachurin SO, et al.
Neurotox Res. 2012 Jul;22(1):33-42. doi: 10.1007/s12640-011-9299-y. Epub 2011 Dec 17.
Neurotox Res. 2012.
PMID: 22179976
Free PMC article.
Item in Clipboard
Dimebon does not ameliorate pathological changes caused by expression of truncated (1-120) human alpha-synuclein in dopaminergic neurons of transgenic mice.
Shelkovnikova TA, Ustyugov AA, Millership S, Peters O, Anichtchik O, Spillantini MG, Buchman VL, Bachurin SO, Ninkina NN.
Shelkovnikova TA, et al.
Neurodegener Dis. 2011;8(6):430-7. doi: 10.1159/000324989. Epub 2011 May 12.
Neurodegener Dis. 2011.
PMID: 21576917
Free PMC article.
Item in Clipboard
Cite
Cite